Differential Regulation of Proteasome Function in Isoproterenol-Induced Cardiac Hypertrophy

被引:91
|
作者
Drews, Oliver [1 ]
Tsukamoto, Osamu [3 ]
Liem, David [1 ]
Streicher, John [2 ]
Wang, Yibin [2 ]
Ping, Peipei [1 ]
机构
[1] Univ Calif Los Angeles, Dept Physiol & Med, David Geffen Sch Med, Los Angeles, CA 90095 USA
[2] Univ Calif Los Angeles, Dept Anesthesiol, David Geffen Sch Med, Los Angeles, CA 90095 USA
[3] Natl Cardiovasc Ctr, Dept Cardiovasc Med, Osaka, Japan
关键词
heart disease; protein degradation; cellular homeostasis; LEFT-VENTRICULAR HYPERTROPHY; HEART-FAILURE; OXIDIZED PROTEINS; PRESSURE-OVERLOAD; 20S PROTEASOME; 26S PROTEASOME; INHIBITORS; ACTIVATION; CELLS; IMMUNOPROTEASOME;
D O I
10.1161/CIRCRESAHA.110.222364
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Rationale: Proteasomal degradation is altered in many disease phenotypes including cardiac hypertrophy, a prevalent condition leading to heart failure. Our recent investigations identified heterogeneous subpopulations of proteasome complexes in the heart and implicated multiple mechanisms for their regulation. Objective: The study aimed at identification of molecular mechanisms changing proteasome function in the hypertrophic heart. Method and Results: Proteasome function, expression, and assembly were analyzed during the development of cardiac hypertrophy induced by beta-adrenergic stimulation. The analysis revealed, for the first time, divergent regulation of proteasome function in cardiac hypertrophy. Proteasome complexes have 3 different proteolytic activities, which are ATP-dependent for 26S complexes (19S assembled with 20S) and ATP-independent for 20S core particles. The 26S activities were enhanced in hypertrophic hearts, partially because of increased expression and assembly of 19S subunits with 20S core complexes. In contrast, caspase-and trypsin-like 20S activities were significantly decreased. Activation of endogenous cAMP-dependent protein kinase (PKA) rescued the depressed 20S functions, supporting the notion that PKA signaling is a positive regulator of protein degradation in the heart. Chymotrypsin-like 20S activity was stably maintained during cardiac remodeling, indicating a switch in proteasome subpopulations, which was supported by altered expression and incorporation of inducible beta subunits. Conclusions: Three novel mechanisms for the regulation of proteasome activities were discovered in the development of cardiac hypertrophy: (1) increased incorporation of inducible subunits in 20S proteasomes; (2) enhanced 20S sensitivity to PKA activation; and (3) increased 26S assembly. PKA modulation of proteasome complexes may provide a novel therapeutic avenue for restoration of cardiac function in the diseased myocardium. (Circ Res. 2010;107:1094-1101.)
引用
收藏
页码:1094 / U91
页数:12
相关论文
共 50 条
  • [1] Differential regulation of cardiac isoforms of protein kinase C in isoproterenol-induced cardiac hypertrophy
    Braun, MU
    Birkner, K
    Pauke, B
    Simonis, G
    Strasser, RH
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1998, 31 (02) : 107A - 107A
  • [2] STUDIES ON ISOPROTERENOL-INDUCED CARDIAC HYPERTROPHY
    STANTON, HC
    [J]. FEDERATION PROCEEDINGS, 1967, 26 (02) : 398 - &
  • [3] Minocycline Blunts Isoproterenol-Induced Cardiac Hypertrophy
    Russell, Jacob
    Bailey, Chastidy
    Brown, Scott
    DeMarco, Vincent G.
    Mummidi, Srinivas
    Bender, Shawn B.
    Chandrasekar, Bysani
    [J]. FASEB JOURNAL, 2022, 36
  • [4] DEVELOPMENT OF ISOPROTERENOL-INDUCED CARDIAC-HYPERTROPHY
    TAYLOR, PB
    TANG, Q
    [J]. CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 1984, 62 (04) : 384 - 389
  • [5] Differential gene expression of adrenomedullin and ANP in isoproterenol-induced cardiac hypertrophy in rats
    Lako-Futo, Z
    Foldes, G
    deChatel, R
    Szokodi, I
    Ruskoaho, H
    Toth, M
    [J]. EUROPEAN HEART JOURNAL, 2000, 21 : 58 - 58
  • [6] Prevention of isoproterenol-induced cardiac hypertrophy by eugenol, an antioxidant
    Choudhary R.
    Mishra K.P.
    Subramanyam C.
    [J]. Indian Journal of Clinical Biochemistry, 2006, 21 (2) : 107 - 113
  • [7] PQQ can improve isoproterenol-induced cardiac hypertrophy
    Li, Yanfei
    Ma, Linlin
    Fang, Wenjuan
    Zhang, Lineng
    Jin, Yueling
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 70 (16) : C16 - C16
  • [8] Apocynin prevents isoproterenol-induced cardiac hypertrophy in rat
    Nikhat Saleem
    Anamika Prasad
    Shyamal K. Goswami
    [J]. Molecular and Cellular Biochemistry, 2018, 445 : 79 - 88
  • [9] Metformin Prevents Isoproterenol-Induced Cardiac Hypertrophy in Mice
    Park, So-Young
    Cha, Hye-Na
    Kim, Yong-Woon
    Kim, Jong-Yeon
    Doh, Kyung-Oh
    Won, Kyung-Chang
    [J]. DIABETES, 2009, 58 : A449 - A449
  • [10] Exercise and Isoproterenol-Induced Cardiac Hypertrophy in Aged Mice
    Luckey, Stephen
    McLaughlin, Nathan
    Soo, Sherilynn
    [J]. FASEB JOURNAL, 2016, 30